Tilray | TRLY - أصول متداولة





أصول متداولة تغيير تاريخ
Acasti Pharma USD 19.21M 1.91M 2025-12
Akebia Therapeutics USD 229.55M 13.93M 2026-06
Alaunos Therapeutics USD 970K 1.02M 2026-03
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Avita Medical AUD 35.49M 760K 2025-12
Canopy Growth CAD 529.47M 4.8M 2026-03
Cronos Group USD 912.03M 15.85M 2026-06
Dianthus Therapeutics USD 897.54M 222.37M 2026-06
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
IQVIA Holdings USD 6.23B 6M 2026-06
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Moderna USD 5.82B 45M 2026-06
Organigram Holdings CAD 250.09M 6.46M 2026-03
Organon & Co USD 5.11B 179M 2026-06
Revvity USD 2.3B 169.4M 2026-06
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Tilray USD 729.32M 28.18M 2025-09
Viatris USD 10.06B 861.1M 2026-06
Xeris Pharmaceuticals USD 274.76M 23.08M 2026-06
Zealand Pharma A/S 15.02B 652.12M 2026-03